Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon.
about
Bypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and RadiotherapyRedox Modulating NRF2: A Potential Mediator of Cancer Stem Cell ResistanceRedox Regulation in Cancer Stem CellsIncreased Oxidative Stress as a Selective Anticancer TherapyReactive oxygen species in cancer stem cellsInvolvement of inflammation and its related microRNAs in hepatocellular carcinomaEffects of shear stresses and antioxidant concentrations on the production of reactive oxygen species in lung cancer cellsGenome-wide profiles of methylation, microRNAs, and gene expression in chemoresistant breast cancerAutocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 ExpressionRole of liver stem cells in hepatocarcinogenesis.Reactive oxygen species in normal and tumor stem cells.P38/NF-κB/snail pathway is involved in caffeic acid-induced inhibition of cancer stem cells-like properties and migratory capacity in malignant human keratinocyte.The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cellsCancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs.Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: a retrospective studyJumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line.Evidence for and against epithelial-to-mesenchymal transition in the liver.Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cellsPeroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive OriginCancer Stem Cells in Hepatocellular Carcinoma.Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.Genotoxic therapy stimulates error-prone DNA repair in dormant hepatocellular cancer stem cells.pIgR: frenemy of inflammation, EMT, and HCC progression.Glutathione peroxidases as oncotargets.The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma.Road to stemness in hepatocellular carcinoma.Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma.RXRα enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC).Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases.Arsenite inhibits the function of CD133+ CD13+ liver cancer stem cells by reducing PML and Oct4 protein expression.The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance.The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy.Crosstalk between the Warburg effect, redox regulation and autophagy induction in tumourigenesis.
P2860
Q26772300-766B67CF-765F-4912-9225-3D5C66CF865BQ26774916-FE696FD6-FBEF-46E3-8C5B-D49477480241Q26798198-7500EE72-7100-4479-BF9F-C696DF2A3E31Q26798210-BEDB45C8-9046-4CE4-B1EC-BC736A9D0509Q26849216-DD574F9B-BF5E-40E8-976A-DCC74057FEF5Q28079138-4D985E58-7CE5-46B4-AD4A-197344386CE9Q28392841-6677926C-DFF0-4F77-8DEA-41E84B1081C3Q29248638-8FEF2B86-B3CC-467F-BC99-580EA57FDC02Q33838977-0A782D53-4F0D-4EE0-9442-E5345440F171Q34259112-D8981B37-B34E-41D5-AE82-CB0339B2F29AQ34392752-6C05319D-17D5-46B8-AC55-F54D432099ABQ34630179-FD15087A-774E-4C15-8BD8-B7FC7F0FDA91Q35164602-7B2E2C9E-03BC-4361-B582-C6F8D736F240Q35280672-4D641717-DF2A-468F-9E8E-027677447C45Q36070349-FF064197-5960-4071-BF49-415AB0EDDDEEQ36983854-9959EF88-AD64-4171-9350-F874EBBD431AQ37377999-146790DC-CADB-4B3F-A7EE-95CDE17ECC96Q37440129-D4616E73-BBBC-4DE6-8C1A-62319B64E244Q37679158-54FC3967-AF8D-43AF-968A-EAF93F4885B4Q37699339-F4C44D9B-9150-4FEC-B5F9-F22DED1AAF62Q38024791-A2547AF6-3869-4F5A-BD48-851C85E329C4Q38287226-5AA0F540-1704-42F5-8924-D664261CDF5CQ38851568-00D6C0D8-AFCB-4025-9883-2BEF1FFE039EQ39124908-9B47D14B-0725-4C22-9ADA-D21523829BDBQ39304072-3074D884-5D05-4094-8913-FF51C9169237Q39393146-1FF264EE-5828-473C-8DE4-CD39AD9C9FA8Q41670848-C27F837B-97C2-4D9E-8F83-B497162ECEC6Q42324416-61BD961F-5620-467B-8663-5449D881F2B3Q42970471-B50C0CCF-5FE8-4CC6-981B-F53783B27091Q46267710-A9F7C6D4-7427-4E69-B5ED-A5F7E32F12D6Q46755879-EEDC9297-A30B-48D5-9F76-CB1BE2A47494Q47137381-CBBFE629-3E6B-430A-A789-D7940358892FQ47395337-0601EC0A-EF09-4B86-9822-B4800D2BE008Q49935401-F6AB6B88-49B6-47BF-B00E-3AC3A7892FA5Q50027179-47533148-EC46-4825-B0B4-3B7590A4839AQ51575389-650DCA9D-D3EF-4E2D-9332-88A0C184042EQ52651786-00D7F050-856B-4A38-9873-42D7FA53AE6AQ53106095-B322C0D4-9590-449A-B3E3-3787BBC70236Q53682156-60F4C9D9-9502-4953-BE96-3D2324731388
P2860
Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Increased CD13 expression redu ...... al transition-like phenomenon.
@en
Increased CD13 expression redu ...... al transition-like phenomenon.
@nl
type
label
Increased CD13 expression redu ...... al transition-like phenomenon.
@en
Increased CD13 expression redu ...... al transition-like phenomenon.
@nl
prefLabel
Increased CD13 expression redu ...... al transition-like phenomenon.
@en
Increased CD13 expression redu ...... al transition-like phenomenon.
@nl
P2093
P2860
P1476
Increased CD13 expression redu ...... al transition-like phenomenon.
@en
P2093
Hideshi Ishii
Hidetoshi Eguchi
Hiroaki Nagano
Hirofumi Yamamoto
Ho Min Kim
Koshi Mimori
Masahisa Ohkuma
Miho Okano
Mitsugu Sekimoto
Naotsugu Haraguchi
P2860
P2888
P304
P356
10.1245/S10434-011-2040-5
P478
19 Suppl 3
P577
2011-08-31T00:00:00Z
P5875
P6179
1012309458